Statistics for Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials
Total visits
| views | |
|---|---|
| Atazanavir—A Once-daily HIV Protease Inhibitor That Does Not Cause Dyslipidemia in Newly Treated Patients: Results from Two Randomized Clinical Trials | 3 |
Total visits per month
| views | |
|---|---|
| octubre 2024 | 0 |
| noviembre 2024 | 0 |
| diciembre 2024 | 0 |
| enero 2025 | 0 |
| febrero 2025 | 0 |
| marzo 2025 | 0 |
| abril 2025 | 0 |
File Visits
| views | |
|---|---|
| 10.1177154510970400300304.pdf | 6 |